Repositioning Family Planning: Guidelines for Advocacy Action
Source:
Academy for Educational Development [AED],
World Health Organization [WHO], Regional Office for Africa,
2008
: 64 pp.
This 64-page guide provides assistance to those working in family planning across Africa to effectively advocate for renewed emphasis on family planning to enhance the visibility, availability, and quality of family planning services. It does not focus on injectables specifically, but can be used as a general tool to guide advocacy efforts.
- Regions/Countries:
- Global
New Study on Use of Injectable Contraceptives and HIV Risk
A new study published in The Lancet Infectious Diseases suggests that use of injectables may double the risk of uninfected women acquiring HIV and of HIV-infected women transmitting the virus to their uninfected partners.
For now, international health organizations and donors, including WHO, UNAIDS, and USAID, caution against making hasty changes to contraceptive policy or practice. (See also USAID's statement in French or Spanish.) WHO is convening a Technical Consultation from 31 January to 1 February 2012 to examine all evidence related to the potential effects of hormonal contraception on HIV acquisition, transmission, and disease progression, and will decide whether modifications need to be made to current WHO guidance. [read more]
Toolkit last updated: 27 January 2012
The information provided on this website is not official U.S. Government information and does not represent the views or position
of the U.S. Agency for International Development, the U.S. Government, or The Johns Hopkins University. Read our full Security & Privacy Policies.